DK1347765T3 - Dermatologiske vandige formuleringer, der indeholder clindamycin og et vandoplöseligt zinksalt - Google Patents

Dermatologiske vandige formuleringer, der indeholder clindamycin og et vandoplöseligt zinksalt

Info

Publication number
DK1347765T3
DK1347765T3 DK01998353T DK01998353T DK1347765T3 DK 1347765 T3 DK1347765 T3 DK 1347765T3 DK 01998353 T DK01998353 T DK 01998353T DK 01998353 T DK01998353 T DK 01998353T DK 1347765 T3 DK1347765 T3 DK 1347765T3
Authority
DK
Denmark
Prior art keywords
zinc salt
water
formulations containing
aqueous formulations
soluble zinc
Prior art date
Application number
DK01998353T
Other languages
English (en)
Inventor
Emma L Strakan Phamac Mcdonagh
Rebecca L Strakan Pharma Kanis
Original Assignee
Strakan Int Ltd
Access Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Strakan Int Ltd, Access Pharma Inc filed Critical Strakan Int Ltd
Application granted granted Critical
Publication of DK1347765T3 publication Critical patent/DK1347765T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK01998353T 2000-11-28 2001-11-28 Dermatologiske vandige formuleringer, der indeholder clindamycin og et vandoplöseligt zinksalt DK1347765T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0029018.9A GB0029018D0 (en) 2000-11-28 2000-11-28 Dermatological formulations

Publications (1)

Publication Number Publication Date
DK1347765T3 true DK1347765T3 (da) 2006-08-07

Family

ID=9904040

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01998353T DK1347765T3 (da) 2000-11-28 2001-11-28 Dermatologiske vandige formuleringer, der indeholder clindamycin og et vandoplöseligt zinksalt

Country Status (25)

Country Link
US (2) US20040109902A1 (da)
EP (1) EP1347765B1 (da)
JP (1) JP4272425B2 (da)
KR (1) KR100629326B1 (da)
AT (1) ATE321560T1 (da)
AU (2) AU2002223091B2 (da)
BR (1) BR0115727A (da)
CA (1) CA2429205C (da)
CZ (1) CZ305272B6 (da)
DE (1) DE60118441T2 (da)
DK (1) DK1347765T3 (da)
ES (1) ES2263689T3 (da)
GB (1) GB0029018D0 (da)
HK (1) HK1059218A1 (da)
HR (1) HRP20030433B1 (da)
HU (1) HUP0400520A3 (da)
IL (1) IL152720A0 (da)
MX (1) MXPA03004733A (da)
NZ (1) NZ526170A (da)
PL (1) PL207221B1 (da)
PT (1) PT1347765E (da)
RU (1) RU2277419C2 (da)
SK (1) SK288111B6 (da)
WO (1) WO2002043739A2 (da)
ZA (1) ZA200305012B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
ES2507070T3 (es) 2006-02-03 2014-10-14 Omp, Inc. Tratamiento antienvejecimiento utilizando composiciones de cobre y zinc
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
CA2701516A1 (en) * 2007-11-30 2009-06-04 Novartis Ag C2-c5-alkyl-imidazole-bisphosphonates
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN109498564B (zh) * 2018-12-21 2021-04-16 贵州景峰注射剂有限公司 一种克林霉素磷酸酯配液及其制备方法
US20230000892A1 (en) * 2021-06-30 2023-01-05 Kenneth Okafor Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
JPS6251619A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd 外用ゲル製剤
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
ZA952521B (en) * 1994-03-28 1996-03-15 Univ Columbia Composition for inactivating irritants in fluids
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
HUP0400520A3 (en) 2012-08-28
BR0115727A (pt) 2003-10-14
ES2263689T3 (es) 2006-12-16
HRP20030433B1 (en) 2007-10-31
EP1347765B1 (en) 2006-03-29
PT1347765E (pt) 2006-08-31
WO2002043739A3 (en) 2003-05-01
HRP20030433A2 (en) 2004-08-31
DE60118441T2 (de) 2006-11-16
IL152720A0 (en) 2003-06-24
CA2429205A1 (en) 2002-06-06
AU2002223091B2 (en) 2006-08-31
DE60118441D1 (de) 2006-05-18
US8268790B2 (en) 2012-09-18
PL207221B1 (pl) 2010-11-30
GB0029018D0 (en) 2001-01-10
US20100173855A1 (en) 2010-07-08
SK6322003A3 (en) 2003-12-02
ATE321560T1 (de) 2006-04-15
CA2429205C (en) 2010-11-16
KR20030069793A (ko) 2003-08-27
KR100629326B1 (ko) 2006-09-29
NZ526170A (en) 2006-01-27
JP4272425B2 (ja) 2009-06-03
JP2004517829A (ja) 2004-06-17
RU2277419C2 (ru) 2006-06-10
CZ305272B6 (cs) 2015-07-15
HUP0400520A2 (hu) 2004-07-28
PL362279A1 (en) 2004-10-18
ZA200305012B (en) 2005-04-26
CZ20031491A3 (cs) 2004-01-14
MXPA03004733A (es) 2005-02-14
SK288111B6 (sk) 2013-08-02
WO2002043739A2 (en) 2002-06-06
EP1347765A2 (en) 2003-10-01
US20040109902A1 (en) 2004-06-10
AU2309102A (en) 2002-06-11
HK1059218A1 (en) 2004-06-25

Similar Documents

Publication Publication Date Title
DK1347765T3 (da) Dermatologiske vandige formuleringer, der indeholder clindamycin og et vandoplöseligt zinksalt
WO2006055008A3 (en) Implantable sensors and implantable pumps and anti-scarring agents
ES2177323T3 (es) Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
TW200612966A (en) Boron-containing compounds and methods of use
HN1999000132A (es) Trifluorometilpirrolcarboxamidas
TR200103811T2 (tr) Mantar öldürücü aktifbileşik kombinasyonları.
WO2003032941A3 (de) Kosmetische und/oder dermatologische wirkstoffkombination
NO20032788D0 (no) Modafinil-forbindelse og cyklodekstrinblandinger
AR032293A1 (es) Estuche farmaceutico
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
ITMI20020189A1 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
EP1023897A3 (en) Dermal agent
DE60112756D1 (de) Racecadotril enthaltende trockene pulverformulierung
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
WO2001062208A3 (de) Topische kosmetische mittel enthaltend 2-hydrazino-1,3-heteroazole
ATE404602T1 (de) Wässrige polyurethanzubereitungen
AR046634A1 (es) Una suspension fungicida acuosa concentrada
DE50114127D1 (de) Torasemid enthaltende lagerstabile pharmazeutische zubereitungen
BR0111485A (pt) Anti-oxidante e preparações para a pele para uso externo
ITTO20001051A0 (it) Perfezionamenti in, o relativi a, attenuatori e dispositivi amplificatori.
AR034554A1 (es) Un metodo para mejorar la distribucion de un ingrediente activo en un licor de curtido, una tableta o bloque para ser usado en dicho metodo, y el uso de dicha tableta o bloque en el curtido de cuero
DE60144383D1 (de) Methoden zur verminderung oder verhinderung von schmerzen mit spicamycin-derivaten
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE60210750D1 (de) Formulierungen von anionischen herbiziden mit kontrollierter wirkstofffreisetzung
EP1319395A3 (de) Stabile wirkstoffhaltige Zubereitungen